Ewing's sarcoma of the mandible

Area of Science:

• Oncology
• Orthopedic Oncology
• Head and Neck Oncology

Background:

• Ewing sarcoma is a rare bone cancer typically affecting long bones.
• Mandibular involvement is infrequent, accounting for only 2% of cases, with maxillary involvement being even rarer.
• The lungs are the most common site for metastases, and increasing pain is the primary symptom.

Observation:

• This report details a case of mandibular Ewing sarcoma in a young male.
• A large, soft tissue mass adjacent to bone destruction in a young male should raise suspicion for this diagnosis.
• Historically, 5- and 10-year survival rates were poor (8% and 4%, respectively).

Findings:

• A revised treatment approach involves four-drug chemotherapy, prophylactic whole-lung irradiation, and local tumor bed irradiation.
• This multimodal therapy has led to achievable 5-year survival rates of 20-30%.
• While local irradiation often replaces surgery for primary long bone tumors, surgical resection may remain the preferred treatment for mandibular Ewing sarcoma.

Implications:

• The updated treatment strategy offers significant hope for improved outcomes in patients with Ewing sarcoma.
• Early diagnosis, particularly in cases of mandibular involvement, is crucial for effective management.
• Further research into optimizing multimodal therapy for rare tumor presentations is warranted.